Looking for volunteers
Preoperative PSMA PET/CT As Triage for EPLND in Patients Scheduled for RALP (PrePSMA)
NCT06398613 · Oslo University Hospital · Updated 31 Dec 2024
- What is being tested
- extended pelvic lymph node dissection (ePLND)
- For
- Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 600 people. The full rules are on the registry page.
- Where
- Norway
- When
- Starts or started 26 April 2024, ends 31 Dec 2029. Registered 3 May 2024.
- Results
- None posted yet.
In the researchers' words
Extended pelvic lymph node dissection (ePLND) is considered the gold standard for nodal staging in men with prostate cancer (PCa). The aim of this project is to determine if preoperative prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomograpy (CT) can safely replace ePLND as a staging method in PCa patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP).
Sites
- Oslo University HospitalOslo, Norway